Clinical trial
Optimizing PENG Block in Hip Arthroplasty: Influence of Ropivacaine Volume and Dexamethasone on Analgesic Efficacy
NCT07023120 is registered in ClinicalTrials.gov with Poznan University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing PENG Block in Hip Arthroplasty: Influence of Ropivacaine Volume and Dexamethasone on Analgesic Efficacy
- Lead sponsor
- Poznan University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 25, 2025
- Completion date
- February 20, 2026
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hip arthritis, hip arthropathy, hip osteoarthritis